Exhibit 10.3

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED, NOR REGISTERED OR QUALIFIED UNDER ANY
STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD,
DELIVERED AFTER SALE, TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS QUALIFIED AND
REGISTERED UNDER APPLICABLE STATE AND FEDERAL SECURITIES LAWS OR UNLESS, IN THE
OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY, SUCH QUALIFICATION
AND REGISTRATION ARE NOT REQUIRED. ANY TRANSFER OF THE SECURITIES REPRESENTED BY
THIS CERTIFICATE IS FURTHER SUBJECT TO OTHER RESTRICTIONS, TERMS AND CONDITIONS
WHICH ARE SET FORTH HEREIN.

 

Ngen Technologies Holdings Corp.

 

Warrant for the Purchase of Shares of Common Stock

 

[Santa Monica Venture Finance, Inc.]

 

Issue Date: March 31, 2020

 

1,405,500 shares of Common Stock, subject to adjustment as set forth herein.

 

THIS CERTIFIES that, for value received, Santa Monica Venture Finance, Inc., a
California corporation (the “Holder”), is entitled to subscribe for and purchase
from Ngen Technologies Holdings Corp., a Nevada corporation (the “Company”),
upon the terms and conditions set forth herein, 1,405,500 shares of common
stock, par value $0.001 per share (the “Common Stock”) of the Company (which
such number of shares subject to adjustment as set forth herein, the “Warrant
Shares”), at an exercise price of $0.0000071149 per Warrant Share (the “Exercise
Price”), as adjusted pursuant to the provisions herein. As used herein the term
“Warrant” shall mean and include this Warrant and warrants hereafter issued as a
consequence of the exercise or transfer of this Warrant in whole or in part. The
Company represents and warrants that the aggregate number of Warrant Shares, as
stated herein, is intended to represent a percentage equal to 31.52% of the
total issued and outstanding shares of the Company, as of the Issue Date,
assuming, for the purposes of the calculation, the full exercise of the Warrant,
as of the Issue Date, and the inclusion of all Warrant Shares in the outstanding
number of shares. In the event that, following the Issue Date and prior to full
exercise of this Warrant, the Company and the Holder determine that there are in
excess of, or less than, 3,053,620 shares of Common Stock issued and outstanding
as of the Issue Date, the number of Warrant Shares for which this Warrant is
exercisable shall be automatically adjusted such that the number of Warrant
Shares equals 31.52% of the total issued and outstanding shares of the Company,
as of the Issue Date, assuming, for the purposes of the calculation, the full
exercise of the Warrant, as of the Issue Date, and the inclusion of all Warrant
Shares in the outstanding number of shares.

 

This Warrant is issued to Holder pursuant to the Restructuring, Settlement and
Release Agreement entered into by and between the Company, the Holder and the
other parties thereto, dated as of March 31, 2020 (the “Restructuring
Agreement”) and is subject to the terms and conditions therein. In the event of
a conflict between the Restructuring Agreement and this Warrant, the terms and
conditions of this Warrant shall control.

 

1

 

 

1. Defined Terms. Defined terms used herein without definition have the meanings
given in the Restructuring Agreement, and the following terms shall have the
following meanings:

 

  (a) “Parties” means the Holder and the Company.         (b) “Party” means
either the Holder or the Company, as applicable.

 

2. Exercise Period. Subject to the terms and conditions set forth herein, this
Warrant may be exercised at any time or from time to time during the ten-year
period commencing on the Issue Date as set forth above and ending of the tenth
anniversary of the date hereof (the “Exercise Period”).     3. Procedure for
Exercise; Effect of Exercise.

 

  (a) Cash Exercise. This Warrant may be exercised, in whole or in part, by the
Holder during normal business hours on any business day during the Exercise
Period by (i) the presentation to the Company at its principal office along of a
duly executed Notice of Exercise (in the form attached hereto) specifying the
number of Warrant Shares to be purchased (each of which shall constitute at
least one share of Common Stock, and integral multiples thereof), and (ii)
delivery of payment to the Company of the aggregate Exercise Price for the
number of Warrant Shares being purchase as specified in the Notice of Exercise
by cash, wire transfer of immediately available funds to a bank account
specified by the Company, or by certified or bank cashier’s check. The Holder
shall not be required to deliver the original Warrant in order to effect an
exercise hereunder. Partial exercises of this Warrant resulting in purchases of
a portion of the total number of Warrant Shares available hereunder shall have
the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares
purchased. Any fractional Warrant Shares that may be issued on exercise of this
Warrant may be issued as such fractional shares of Common Stock, may be paid in
cash or may be rounded up to the next nearest share of Common Stock, in each
case at the election of the Company.         (b) Cashless Exercise.
Notwithstanding Section 3(a) if the “Fair Market Value” (as defined below) of
one share of Common Stock is greater than the Exercise Price, the Holder may
elect to receive Warrant Shares pursuant to a cashless exercise, in lieu of a
cash exercise, equal to the value of this Warrant determined in the manner
described below (or of any portion thereof remaining unexercised) by surrender
of this Warrant and a Notice of Exercise, in which event the Company shall issue
to Holder a number of Common Stock computed using the following formula:

 

X = Y (A-B)

 

A

 

Where:

 

  X = the number of Warrant Shares to be issued to Holder.         Y = the
number of Warrant Shares that the Holder elects to purchase under this Warrant
(at the date of such calculation).

 

2

 

 

  A = Fair Market Value of a Warrant Share at the date of such calculation.    
    B = Exercise Price, as adjusted to the date of calculation.

 

For purposes of this Warrant, the per share “Fair Market Value” shall mean (i)
if the Common Stock is then listed for trading on the OTC Markets or a United
States or Canadian national securities exchange (as applicable, the “Trading
Market”), the highest traded price of the Common Stock during the twenty (20)
day period during which the Common Stock is then tradeable on the primary
Trading Market prior to the date of the applicable Exercise Notice or (ii) if
the Common Stock is not then listed for trading on the OTC Markets or a United
States or Canadian national securities exchange, the per share fair market value
of the Warrant Shares as is determined in good faith by the Board of Directors
of the Company after taking into consideration factors it deems appropriate,
Including, without limitation, recent sale and offer prices of the capital stock
of the Company in private transactions negotiated at arm’s length.

 

  (c) Effect of Exercise. Upon receipt by the Company of this Warrant and a
Notice of Exercise, together with proper payment of the Exercise Price (if
applicable), as provided herein, the Company agrees that such Warrant Shares
shall be deemed to be issued to the Holder as the record holder of such Warrant
Shares as of the close of business on the date on which the Notice of Exercise
has been delivered and payment has been made for such Warrant Shares in
accordance with this Warrant and the Holder shall be deemed to be the holder of
record of the Warrant Shares, notwithstanding that the stock transfer books of
the Company shall then be closed or that certificates representing such Warrant
Shares shall not then be actually delivered to the Holder. A stock certificate
or certificates for the Warrant Shares specified in the Notice of Exercise shall
be delivered to the Holder as promptly as practicable, and in any event within
three (3) business days, thereafter. The stock certificate(s) so delivered shall
be in any such denominations as may be reasonably specified by the Holder in the
Notice of Exercise.         (d) Certain Adjustments. The number and kind of
securities purchasable upon the exercise of this Warrant and the Exercise Price
therefor shall be subject to adjustment from time to time upon the occurrence of
certain events, as follows:

 

  (i) Adjustments Due to Splits and Stock Dividends. If at any time while this
Warrant is outstanding, the Company: (x) pays a dividend or makes any other
distribution upon the shares, or any other securities of the Company, payable in
shares, convertible securities or equity-linked securities of the Company, or
(y) effects a forward split or reverse split of the Common Stock, which shall
include a recapitalization, combination or otherwise, the number of Warrant
Shares shall be appropriately adjusted, with any partial resulting Warrant Share
being rounded up to the next nearest whole number, and the Exercise Price shall
be proportionately adjusted such that the aggregate Exercise Price payable
hereunder shall remain unchanged. By way of example and not limitation, (i) in
the event that the Company effects a two-for-one forward split of the Common
Stock, wherein each issued and outstanding share of Common Stock is converted
into two shares of Common Stock, the number of Warrant Shares shall be doubled
and the Exercise Price shall be reduced by 50% and (ii) in the event that the
Company effects a one-for-two reverse split of the Common Stock, wherein each
two issued and outstanding shares of Common Stock are converted into one share
of Common Stock, the number of Warrant Shares shall be reduced by 50% and the
Exercise Price shall be doubled.

 

3

 

 

  (ii) Adjustments Due to Share Issuances. In at any time while this Warrant is
outstanding, the Company issues any shares of Common Stock upon conversion of
any promissory notes, exercise of warrants or other convertible or equity-linked
securities, which in each case are issued and outstanding as of the Issue Date
as set forth above and which are held by any of Carebourn Capital, LP, a
Delaware Limited Partnership (“CareBourn LP”), CareBourn, LLC, a Nevada limited
liability company (“CareBourn LLC”), More Capital LLC, a Minnesota limited
liability company (“More Capital”), or Auctus Fund, LLC, a Delaware limited
liability company (“Auctus”), then the number of Warrant Shares shall be
appropriately adjusted to add a number of Warrant Shares hereunder equal to (i)
the number of shares of Common Stock issued CareBourn LP, CareBourn LLC, More
Capital or Auctus, as applicable, multiplied by (ii) 46%. By way of example and
not limitation, in the event that CareBourn LP exercises a warrant referenced
above and acquires 100 shares of Common Stock thereunder, this Warrant shall be
automatically adjustment to add 46 Warrant Shares to the total number of Warrant
Shares which may be acquired hereunder, with the intent that Holder retains the
right to acquire 31.52% of the issued and outstanding shares of Common Stock at
such time. The Company represents and warrants none of the securities held by
CareBourn LP, CareBourn LLC, More Capital and Auctus entitle the holder to
receive any dividends or distributions from the Company unless the security is
first converted into shares of Common Stock. The Company further represents and
warrants that, as of the Issue Date, the only class of stock of the Company that
is issued and outstanding is Common Stock.         (iii) Fundamental
Transactions. In the event that, prior to any exercise hereunder, the Common
Stock is converted into another class of securities of the Company or any
successor entity to the Company, whether by way of merger, reorganization, re-
incorporation or otherwise (the “Replacement Securities”), any reference herein
to the Common Stock (whether standing alone or as part of another defined term
herein) automatically upon the consummation of the applicable transaction shall
be deemed a reference to such Replacement Securities. In the event that, prior
to any exercise hereunder, the Company completes a share exchange with another
entity wherein all of the issued and outstanding shares of Common Stock are
exchanged for equity interests in the other entity (the “Exchanged Securities”),
any reference herein to the Common Stock (whether standing alone or as part of
another defined term herein) automatically upon the consummation of the
applicable transaction shall be deemed a reference to such Exchanged Securities.
Then, upon any subsequent exercise of this Warrant, the Holder shall have the
right to receive the number of Replacement Securities or Exchanged Securities
and any additional consideration (the “Alternate Consideration”) receivable upon
or as a result of such merger, reorganization, re-incorporation or exchange as
receivable for the Warrant Shares had they been issued at that time, with
appropriate and equitable adjustments being made to the Exercise Price, and for
purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the
amount of Alternate Consideration issuable in respect of one share of Common
Stock.

 

4

 

 

  (iv) Notice of Adjustments. Whenever the number of Warrant Shares purchasable
hereunder or the Exercise Price thereof shall be adjusted pursuant hereto, the
Company shall provide notice to the Holder setting forth, in reasonable detail,
the event requiring the adjustment, the amount of the adjustment, the method by
which such adjustment was calculated, and the number and class of shares which
may be purchased thereafter and the Exercise Price therefor after giving effect
to such adjustment.

 

  (e) Holder’s Exercise Limitations. The Company shall not effect any exercise
of this Warrant, and a Holder shall not have the right to exercise any portion
of this Warrant, to the extent that after giving effect to the conversion set
forth on the applicable Notice of Exercise, the Holder (together with the
Holder’s Affiliates, and any other Persons acting as a group together with the
Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”))
would beneficially own in excess of the Beneficial Ownership Limitation (as
defined below). For purposes of the foregoing sentence, the number of shares of
Common Stock beneficially owned by the Holder and its Affiliates and Attribution
Parties shall include the number of shares of Common Stock issuable upon
exercise of this Warrant with respect to which such determination is being made,
but shall exclude the number of shares of Common Stock which are issuable upon
(i) exercise of the remaining, non-exercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties
and (ii) exercise or conversion of the unexercised or unconverted portion of any
other securities of the Company subject to a limitation on conversion or
exercise analogous to the limitation contained herein (including, without
limitation, the Note or any other Warrants) beneficially owned by the Holder or
any of its Affiliates or Attribution Parties. Except as set forth in the
preceding sentence, for purposes of this Section 3(e), beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act, and
the rules and regulations promulgated thereunder. To the extent that the
limitation contained in this Section 3(e) applies, the determination of whether
this Warrant is exercisable (in relation to other securities owned by the Holder
together with any Affiliates and Attribution Parties) and of which this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission
of a Notice of Exercise shall be deemed to be the Holder’s determination of
whether this Warrant may be exercised (in relation to other securities owned by
the Holder together with any Affiliates or Attribution Parties) and which
portion of this Warrant may be exercised, in each case subject to the Beneficial
Ownership Limitation. To ensure compliance with this restriction, the Holder
will be deemed to represent to the Company each time it delivers a Notice of
Exercise that such Notice of Exercise has not violated the restrictions set
forth in this Section 3(e) and the Company shall have no obligation to verify or
confirm the accuracy of such determination. In addition, a determination as to
any group status as contemplated above shall be determined in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 3(e) in determining the number of
outstanding shares of Common Stock, the Holder may rely on the number of
outstanding shares of Common Stock as stated in the most recent of the
following: (i) the Company’s most recent periodic or annual report filed with
the SEC, as the case may be, (ii) a more recent public announcement by the
Company, or (iii) a more recent written notice by the Company or the Company’s
transfer agent setting forth the number of shares of Common Stock outstanding.
Upon the written or oral request of a Holder, the Company shall within one
Business Day confirm orally and in writing to the Holder the number of shares of
Common Stock then outstanding. In any case, the number of outstanding shares of
Common Stock shall be determined after giving effect to the conversion or
exercise of securities of the Company, including this Warrant, by the Holder or
its Affiliates since the date as of which such number of outstanding shares of
Common Stock was reported. The “Beneficial Ownership Limitation” shall be 9.99%
of the number of shares of Common Stock outstanding immediately after giving
effect to the issuance of shares of Common Stock issuable upon exercise of this
Warrant by the Holder. The Holder, upon notice to the Company, may increase or
decrease the Beneficial Ownership Limitation provisions of this Section 3(e)
provided that any increase in the Beneficial Ownership Limitation will not be
effective until the 61st day after such notice is delivered to the Company. The
Beneficial Ownership Limitation provisions of this Section 3(e) shall be
construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 3(e) to correct this Section 3(e) (or any portion
hereof) which may be defective or inconsistent with the intended Beneficial
Ownership Limitation contained herein or to make changes or supplements
necessary or desirable to properly give effect to such limitation. The
limitations contained in this Section 3(e) shall apply to a successor holder of
this Warrant.

 

5

 

 

  (f) Conditional Exercise. Notwithstanding any other provision hereof, if an
exercise of any portion of this Warrant is to be made in connection with a
public offering or a sale of the Company (pursuant to a merger, sale of
securities or assets, or otherwise), such exercise may at the election of the
Holder be conditioned upon the consummation of such transaction, in which case
such exercise shall not be deemed to be effective until immediately prior to the
consummation of such transaction.

 

4. Notices. In the event that, at any time while this Warrant is outstanding:

 

  (i) the Company shall take a record of the holders of its shares for the
purpose of entitling or enabling them to receive any dividend or other
distribution, to vote at a meeting (or by written consent), to receive any right
to subscribe for or purchase any securities, or to receive any other security;  
      (ii) the Company shall undertake any capital reorganization of the
Company, any reclassification of the shares of the Company, any consolidation or
merger of the Company with or into another Person, or sale of all or
substantially all of the Company’s assets to another Person; or         (iii)
 the Company shall undertake any voluntary or involuntary dissolution,
liquidation or winding-up of the Company;

 

then, and in each such case, the Company shall send or cause to be sent to the
Holder at least thirty (30) days prior to the applicable record date or the
applicable expected effective date, as the case may be, for the event, a written
notice specifying, as the case may be, (A) the record date for such dividend,
distribution, meeting or consent or other right or action, and a description of
such dividend, distribution or other right or action to be taken at such meeting
or by written consent, or (B) the effective date on which such reorganization,
reclassification, consolidation, merger, sale, dissolution, liquidation or
winding-up is proposed to take place, and the date, if any is to be fixed, as of
which the books of the Company shall close or a record shall be taken with
respect to which the holders of record of the shares (or shares issuable upon
exercise of the Warrant at that time) shall be entitled to exchange their shares
(or such other securities) for securities or other property deliverable upon
such reorganization, reclassification, consolidation, merger, sale, dissolution,
liquidation or winding-up, and the amount per unit and character of such
exchange applicable to the Warrant and the Warrant Shares.

 

6

 

 

5. Registration of Warrants; Transfer of Warrants. Any Warrants issued upon the
transfer or exercise in part of this Warrant shall be numbered and shall be
registered in a Warrant Register as they are issued. The Company shall be
entitled to treat the registered holder of any Warrant on the Warrant Register
as the owner in fact thereof for all purposes and shall not be bound to
recognize any equitable or other claim to or interest in such Warrant on the
part of any other person, and shall not be liable for any registration or
transfer of Warrants which are registered or to be registered in the name of a
fiduciary or the nominee of a fiduciary unless made with the actual knowledge
that a fiduciary or nominee is committing a breach of trust in requesting such
registration or transfer, or with the knowledge of such facts that its
participation therein amounts to bad faith. This Warrant shall be transferable
only on the books of the Company upon delivery thereof duly endorsed by the
Holder or by its duly authorized attorney or representative, or accompanied by
proper evidence of succession, assignment, or authority to transfer. In all
cases of transfer by an attorney, executor, administrator, guardian, or other
legal representative, duly authenticated evidence of his or its authority shall
be produced. Upon any registration of transfer, the Company shall deliver a new
Warrant or Warrants to the person entitled thereto. This Warrant may be
exchanged, at the option of the Holder thereof, for another Warrant, or other
Warrants of different denominations, of like tenor and representing in the
aggregate the right to purchase a like number of Warrant Shares, upon surrender
to the Company or its duly authorized agent.     6. Restrictions on Transfer.

 

  (a) The Holder, as of the Issuance Date, represents to the Company that such
Holder is acquiring this Warrant for its own account for investment purposes and
not with a view to the distribution thereof or of the Warrant Shares.
Notwithstanding any provisions contained in this Warrant to the contrary, this
Warrant, or any portion thereof, and the related Warrant Shares shall not be
transferable except pursuant to the proviso contained in the following sentence
or upon the conditions specified in this Section 6, which conditions are
intended, among other things, to insure compliance with the provisions of the
Securities Act of 1933, as amended (the “Securities Act”) and applicable state
law in respect of the transfer of this Warrant or such Warrant Shares. The
Holder by acceptance of this Warrant agrees that the Holder will not transfer
this Warrant or the related Warrant Shares prior to delivery to the Company of
an opinion of the Holder’s counsel (as such opinion and such counsel are
described in Section 6(b)) or until registration of such Warrant Shares under
the Securities Act has become effective or after a sale of such Warrant or
Warrant Shares has been consummated pursuant to Rule 144 or Rule 144A under the
Securities Act; provided, however, that the Holder may freely transfer this
Warrant, any portion thereof, or such Warrant Shares (without delivery to the
Company of an opinion of counsel) (i) to one of its nominees, affiliates (which
shall include Yaakov G. Vanek or Eric J. Weissman) or a nominee thereof, (ii)
from a nominee to any of the aforementioned persons as beneficial owner of this
Warrant or such Warrant Shares, (iii) to a qualified institutional buyer, so
long as such transfer is effected in compliance with Rule 144A under the
Securities Act, or (iv) to an accredited investor (as such term is defined in
Regulation D under the Securities Act).

 

7

 

 

  (b) The Holder, by its acceptance hereof, agrees that prior to any transfer of
this Warrant or of the related Warrant Shares (other than as permitted by
Section 6(a) or pursuant to a registration under the Securities Act), the Holder
will give written notice to the Company of its intention to effect such
transfer, together with an opinion of such counsel for the Holder as shall be
reasonably acceptable to the Company, to the effect that the proposed transfer
of this Warrant and/or such Warrant Shares may be effected without registration
under the Securities Act. Upon delivery of such notice and opinion, if required,
to the Company, the Holder shall be entitled to transfer this Warrant and/or
such Warrant Shares in accordance with the intended method of disposition
specified in the notice to the Company and the Company shall execute and deliver
a new Warrant or Warrants in the name of the assignee or assignees and in the
denominations specified in such instrument of assignment, and shall issue to the
assignor a new Warrant evidencing the portion of this Warrant, if any, not so
assigned and this Warrant shall promptly be cancelled.         (c) Upon any
transfer of this Warrant, the Company shall issue a replacement warrant to the
transferee (the “Replacement Warrant”) which shall have provisions providing to
the transferee the same economic interest in the Warrant Shares and otherwise
having tenor herein, but which Replacement Warrant the Company and the Holder
agree shall not be connected or linked to the Restructuring Agreement and shall
be a standalone customary warrant agreement, in form and substance as reasonably
agreed to by the Company and the Holder. By way of example and not limitation,
the provisions of Section 11, Section 14, Section 16(a) and Section 16(f) shall
be appropriately revised in the Replacement Warrant. Upon any issuance of a
Replacement Warrant, this Warrant shall also be amended to reduce the number of
Warrant Shares exercisable hereunder.         (d) Each stock certificate
representing Warrant Shares issued upon exercise or exchange of this Warrant
shall bear the following legend unless the opinion of counsel referred to in
Section 6(a) states such legend is not required:

 

“THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN
EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN
WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE
501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.”

 

7. Reservation of Shares; Reissuance. The Company shall at all times during the
Exercise Period reserve and keep available out of its authorized and unissued
Common Stock, solely for the purpose of providing for the exercise of the rights
to purchase all Warrant Shares granted pursuant to the Warrants, such number of
shares of Common Stock as shall, from time to time, be sufficient therefor. The
Company covenants that all shares of Common Stock issuable upon exercise of this
Warrant, upon receipt by the Company of the full Exercise Price therefor, shall
be validly issued, fully paid, non-assessable, and free of preemptive rights,
and free from all taxes, claims, liens, charges and other encumbrances. If this
Warrant is lost, stolen, mutilated or destroyed, the Company will, on such terms
as to indemnity or otherwise as it may reasonably impose (which shall, in the
case of a mutilated Warrant, include the surrender thereof), issue a new Warrant
of like denomination and tenor as this Warrant so lost, stolen, mutilated or
destroyed. In the event that this Warrant is not fully exercised by the end of
the Exercise Period it shall thereafter be void and of no further force and
effect.

 

8

 

 

8. No Impairment and Non-Circumvention. The Company shall not, by amendment of
its articles of incorporation or bylaws, or through any reorganization, transfer
of assets, consolidation, merger, dissolution, issue or sale of securities, or
any other voluntary action, avoid, or seek to avoid, the observance or
performance of any of the terms to be observed or performed by it hereunder. The
Company shall at all times in good faith assist in the carrying out of all the
provisions of this Warrant and in the taking of all such action as may
reasonably be requested by the Holder in order to protect the rights of the
Holder, including, but not limited to, providing the Holder with the Company’s
and its subsidiaries’ financial information.     9. Transfer Taxes. The issuance
of any shares or other securities upon the exercise of this Warrant, and the
delivery of certificates or other instruments representing such shares or other
securities, shall be made without charge to the Holder (or its nominees or
affiliates as defined above) for any tax or other charge in respect of such
issuance. The Company shall not, however, be required to pay any tax which may
be payable in respect of any transfer involved in the issue and delivery of any
certificate in a name other than that of the above referenced persons and the
Company shall not be required to issue or deliver any such certificate unless
and until the person or persons requesting the issue thereof shall have paid to
the Company the amount of such tax or shall have established to the satisfaction
of the Company that such tax has been paid.     10. Holder Not Deemed a
Shareholder; No Liability. Prior to the issuance to the Holder of the Warrant
Shares to which the Holder is then entitled to receive upon the due exercise of
this Warrant, the Holder shall not be deemed the holder of shares of the Company
for any purpose (unless the Holder otherwise holds shares of the Company
independent of this Warrant). In addition, subject to the provision in the
foregoing sentence, nothing contained in this Warrant shall be construed as
imposing any liabilities on the Holder: (i) as a shareholder of the Company,
whether such liabilities are asserted by the Company or by any other person,
including creditors of the Company, or (ii) to purchase any securities (by
exercise of this Warrant or otherwise).     11. Resolution of Disputes. Any
dispute, claim, or controversy arising out of or relating to this Warrant
(including with respect to the meaning, effect, validity, termination,
interpretation, performance, or enforcement of this Warrant) or any alleged
breach thereof (including any action in tort, contract, equity, or otherwise),
shall be resolved in accordance with the “Resolution of Disputes” provision of
the Restructuring Agreement.     12. Governing Law; Consent to Jurisdiction.
This Warrant shall be governed, construed and enforced in accordance with the
Laws of the State of Nevada, without application of the conflicts of laws
provisions thereof. Subject to Section 11, each Party agrees that all legal
proceedings concerning the interpretation, enforcement and defense of the
transactions contemplated by this Warrant (whether brought against a Party
hereto or its respective Affiliates, directors, officers, shareholders,
employees or agents) shall be commenced in the state and federal courts sitting
in Dallas County, Texas (the “Selected Courts”). Each Party hereto hereby
irrevocably submits to the exclusive jurisdiction of the Selected Courts for the
adjudication of any dispute hereunder or in connection herewith or with any
transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of such Selected Courts,
or such Selected Courts are improper or inconvenient venue for such proceeding.
Each Party hereby irrevocably waives personal service of process and consents to
process being served in any such suit, action or proceeding by mailing a copy
thereof via registered or certified mail or overnight delivery (with evidence of
delivery) to such Party at the address in effect for notices to it under this
Warrant and agrees that such service shall constitute good and sufficient
service of process and notice thereof.

 

9

 

 

13. Waiver of Jury Trial; Exemplary Damages.

 

  (a) EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY
APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING
DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE
TRANSACTIONS CONTEMPLATED HEREIN (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER
THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR
ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH
OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING
WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN
INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS
AND CERTIFICATIONS IN THIS SECTION 13(a).         (b) Each of the Parties
acknowledge that each has been represented in connection with the signing of the
waiver set forth in Section 13(a) by independent legal counsel selected by the
respective Party and that such Party has discussed the legal consequences and
import of such waiver with legal counsel. Each of the Parties further
acknowledge that each has read and understands the meaning of such waiver and
grants such waiver knowingly, voluntarily, without duress and only after
consideration of the consequences of this waiver with legal counsel.         (c)
IN NO EVENT WILL ANY PARTY BE LIABLE TO ANY OTHER PARTY UNDER OR IN CONNECTION
WITH THIS WARRANT OR IN CONNECTION WITH THE TRANSACTIONS CONTEMPLATED HEREIN FOR
SPECIAL, GENERAL, INDIRECT, CONSEQUENTIAL, OR PUNITIVE OR EXEMPLARY DAMAGES,
INCLUDING DAMAGES FOR LOST PROFITS OR LOST OPPORTUNITY, EVEN IF THE PARTY SOUGHT
TO BE HELD LIABLE HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.

 

14. Indemnification. The Company and the Holder agree that the indemnification
provisions of the Restructuring Agreement shall apply to this Warrant.     15.
Specific Performance. The Parties agree that irreparable damage would occur in
the event that any of the provisions of this Warrant were not performed by them
in accordance with the terms hereof or were otherwise breached and that each
Party hereto shall be entitled to an injunction or injunctions, specific
performance and other equitable relief to prevent breaches of the provisions
hereof and to enforce specifically the terms and provisions hereof, without the
proof of actual damages, in addition to any other remedy to which they are
entitled at law or in equity. Each Party agrees to waive any requirement for the
security or posting of any bond in connection with any such equitable remedy,
and agrees that it will not oppose the granting of an injunction, specific
performance or other equitable relief on the basis that (a) the other Party has
an adequate remedy at law, or (b) an award of specific performance is not an
appropriate remedy for any reason at law or equity.

 

10

 

 

16. Miscellaneous.

 

  (a) Notices. Any notice or other communications required or permitted
hereunder shall be given in accordance with the terms and conditions of the
Restructuring Agreement.         (b) Absolute Obligation. Except as expressly
provided herein, no provision of this Warrant shall alter or impair the
obligations of the Company, which are absolute and unconditional.         (c)
Lost or Mutilated Warrant. If this Warrant shall be mutilated, lost, stolen or
destroyed, the Company shall execute and deliver, in exchange and substitution
for and upon cancellation of a mutilated Warrant, or in lieu of or in
substitution for a lost, stolen or destroyed Warrant, a new Warrant so
mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such
loss, theft or destruction of this Warrant, and of the ownership hereof
reasonably satisfactory to the Company.         (d) Attorneys’ Fees. In the
event that any Party institutes any action or suit to enforce this Warrant or to
secure relief from any default hereunder or breach hereof, the prevailing Party
shall be reimbursed by the losing Party for all costs, including reasonable
attorney’s fees, incurred in connection therewith and in enforcing or collecting
any judgment rendered therein.         (e) Severability. If any term or
provision of this Warrant is held by a court of competent jurisdiction or other
authority to be invalid, void or unenforceable in any situation in any
jurisdiction, such determination shall not affect the validity or enforceability
of the remaining terms and provisions hereof or thereof or the validity or
enforceability of the offending term or provision in any other situation or in
any other jurisdiction. If the final judgment of a court of competent
jurisdiction or other authority declares that any term or provision hereof or
thereof is invalid, void or unenforceable, each of the Company and the Holder
agrees that the court making such determination shall have the power to reduce
the scope, duration, area or applicability of the term or provision; to delete
specific words or phrases; or to replace any invalid, void or unenforceable term
or provision with a term or provision that is valid and enforceable and that
comes closest to expressing the intention of the invalid, void or unenforceable
term or provision.         (f) Entire Agreement. This Warrant and the other
Transaction Documents constitute the entire agreement between the Parties with
respect to the subject matter hereof and thereof and supersede all prior
agreements, understandings and negotiations, whether written or oral, of the
Parties.

 

11

 

 

  (g) Arm’s Length Bargaining; No Presumption Against Drafter. This Warrant has
been negotiated at arm’s-length by parties of equal bargaining strength, each
represented by counsel or having had but declined the opportunity to be
represented by counsel and having participated in the drafting of this Warrant.
This Warrant creates no fiduciary or other special relationship between the
Parties, and no such relationship otherwise exists. No presumption in favor of
or against any Party in the construction or interpretation of this Warrant or
any provision hereof shall be made based upon which Person might have drafted
this Warrant or such provision.         (h) Amendment; Waiver. Other than as
specifically set forth herein, this Warrant may be amended, and the observance
of any term hereof may be waived (either retroactively or prospectively), only
upon the written consent of the Company and the Holder.         (i) Descriptive
Headings. The descriptive headings herein are inserted for convenience of
reference only and shall in no way be construed to define, limit, describe,
explain, modify, amplify, or add to the interpretation, construction or meaning
of any provision of, or scope or intent of, this Warrant nor in any way affect
this Warrant.         (j) Third Party Beneficiaries. This contract is strictly
between the Parties and, except as specifically provided, no other Person and no
director, officer, shareholder, employee, agent, independent contractor or any
other Person shall be deemed to be a third-party beneficiary of this Warrant.  
      (k) Currency. All dollar amounts are in U.S. dollars.

 

[SIGNATURE PAGE FOLLOWS]

 

12

 

 

Issuance date: March 31, 2020

 

  Ngen Technologies Holdings Corp.         By: /s/ Ed Carter   Name: Ed Carter  
Title: Chief Executive Officer

 

13

 

 

NOTICE OF EXERCISE

 

To: Ngen Technologies Holdings Corp.       Attention: Chief Executive Officer

 

THE UNDERSIGNED holder hereby exercises the right to purchase______________of
the shares of Common Stock (“Warrant Shares”) of Ngen Technologies Holdings
Corp., a Nevada corporation (the “Company”), evidenced by the attached copy of
the Warrant to Purchase Shares of Common Stock (the “Warrant”). Capitalized
terms used herein and not otherwise defined shall have the respective meanings
set forth in the Warrant.

 

1. Form of Exercise Price. The Holder intends that payment of the Exercise Price
shall be made as (check one):

 

  [  ] a cash exercise with respect to___________________Warrant Shares; or    
    [  ] by cashless exercise pursuant to the Warrant.

 

2. Payment of Exercise Price. If cash exercise is selected above, the holder
shall pay the applicable aggregate Exercise Price in the sum of
$________________________to the Company in accordance with the terms of the
Warrant.     3. Delivery of Warrant Shares. The Company shall deliver to the
holder___________________Warrant Shares, to:

 

(Print Name, Address and Social Security or Tax Identification Number)

 

 

 

 

 

 

 

 

 

 

 

If such number of Warrant Shares shall not be all the Warrant Shares covered by
the within Warrant, a new Warrant for the balance of the Warrant Shares covered
by the within Warrant be registered in the name of, and delivered to, the
undersigned at the address stated above.

 

Dated:           Name:           By:     Name:     Title: